1 Study Coverage

• 1.1 Injectable Blood Thinners Product Introduction
• 1.2 Global Injectable Blood Thinners Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Injectable Blood Thinners Sales in US$ Million for the Year 2017-2028

1.2.2 Global Injectable Blood Thinners Sales in Volume for the Year 2017-2028

1.3 United States Injectable Blood Thinners Outlook 2017 VS 2022 VS 2028

1.3.1 United States Injectable Blood Thinners Sales in US$ Million for the Year 2017-2028

1.3.2 United States Injectable Blood Thinners Sales in Volume for the Year 2017-2028

1.4 Injectable Blood Thinners Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4.1 The Market Share of United States Injectable Blood Thinners in Global, 2017 VS 2022 VS 2028

1.4.2 The Growth Rate of Injectable Blood Thinners Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.5 Injectable Blood Thinners Market Dynamics

1.5.1 Injectable Blood Thinners Industry Trends

1.5.2 Injectable Blood Thinners Market Drivers

1.5.3 Injectable Blood Thinners Market Challenges

1.5.4 Injectable Blood Thinners Market Restraints

1.6 Study Objectives

1.7 Years Considered

2 Market by Type

• 2.1 Injectable Blood Thinners Market Segment by Type
• 2.1.1 LMWH

2.1.2 Unfractionated Heparin

2.1.3 Fibrinolytics

2.1.4 Other

2.2 Global Injectable Blood Thinners Market Size by Type

2.2.1 Global Injectable Blood Thinners Sales in Value, by Type (2017, 2022 & 2028)

2.2.2 Global Injectable Blood Thinners Sales in Volume, by Type (2017, 2022 & 2028)

2.2.3 Global Injectable Blood Thinners Average Selling Price (ASP) by Type (2017, 2022 & 2028)

2.3 United States Injectable Blood Thinners Market Size by Type

2.3.1 United States Injectable Blood Thinners Sales in Value, by Type (2017, 2022 & 2028)

2.3.2 United States Injectable Blood Thinners Sales in Volume, by Type (2017, 2022 & 2028)

2.3.3 United States Injectable Blood Thinners Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Injectable Blood Thinners Market Segment by Application
• 3.1.1 Hospital

3.1.2 Clinic

3.1.3 Others

3.2 Global Injectable Blood Thinners Market Size by Application

3.2.1 Global Injectable Blood Thinners Sales in Value, by Application (2017, 2022 & 2028)

3.2.2 Global Injectable Blood Thinners Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 Global Injectable Blood Thinners Average Selling Price (ASP) by Application (2017, 2022 & 2028)

3.3 United States Injectable Blood Thinners Market Size by Application

3.3.1 United States Injectable Blood Thinners Sales in Value, by Application (2017, 2022 & 2028)

3.3.2 United States Injectable Blood Thinners Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 United States Injectable Blood Thinners Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Injectable Blood Thinners Competitor Landscape by Company

• 4.1 Global Injectable Blood Thinners Market Size by Company
• 4.1.1 Top Global Injectable Blood Thinners Manufacturers Ranked by Revenue (2021)

4.1.2 Global Injectable Blood Thinners Revenue by Manufacturer (2017-2022)

4.1.3 Global Injectable Blood Thinners Sales by Manufacturer (2017-2022)

4.1.4 Global Injectable Blood Thinners Price by Manufacturer (2017-2022)

4.2 Global Injectable Blood Thinners Concentration Ratio (CR)

4.2.1 Injectable Blood Thinners Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Injectable Blood Thinners in 2021

4.2.3 Global Injectable Blood Thinners Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Injectable Blood Thinners Manufacturing Base Distribution, Product Type

4.3.1 Global Injectable Blood Thinners Manufacturers, Headquarters and Distribution of Producing Region

4.3.2 Manufacturers Injectable Blood Thinners Product Type

4.3.3 Date of International Manufacturers Enter into Injectable Blood Thinners Market

4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

4.5 United States Injectable Blood Thinners Market Size by Company

4.5.1 Top Injectable Blood Thinners Players in United States, Ranked by Revenue (2021)

4.5.2 United States Injectable Blood Thinners Revenue by Players (2020, 2021 & 2022)

4.5.3 United States Injectable Blood Thinners Sales by Players (2020, 2021 & 2022)

5 Global Injectable Blood Thinners Market Size by Region

• 5.1 Global Injectable Blood Thinners Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Injectable Blood Thinners Market Size in Volume by Region (2017-2028)
• 5.2.1 Global Injectable Blood Thinners Sales in Volume by Region: 2017-2022

5.2.2 Global Injectable Blood Thinners Sales in Volume Forecast by Region (2023-2028)

5.3 Global Injectable Blood Thinners Market Size in Value by Region (2017-2028)

5.3.1 Global Injectable Blood Thinners Sales in Value by Region: 2017-2022

5.3.2 Global Injectable Blood Thinners Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Injectable Blood Thinners Market Size YoY Growth 2017-2028

6.1.2 North America Injectable Blood Thinners Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Injectable Blood Thinners Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Injectable Blood Thinners Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Injectable Blood Thinners Market Size YoY Growth 2017-2028

6.3.2 Europe Injectable Blood Thinners Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Injectable Blood Thinners Market Size YoY Growth 2017-2028

6.4.2 Latin America Injectable Blood Thinners Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.4.6 Colombia

6.5 Middle East and Africa

6.5.1 Middle East and Africa Injectable Blood Thinners Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Injectable Blood Thinners Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Sanofi
• 7.1.1 Sanofi Corporation Information

7.1.2 Sanofi Description and Business Overview

7.1.3 Sanofi Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.1.4 Sanofi Injectable Blood Thinners Products Offered

7.1.5 Sanofi Recent Development

7.2 Genentech (Roche)

7.2.1 Genentech (Roche) Corporation Information

7.2.2 Genentech (Roche) Description and Business Overview

7.2.3 Genentech (Roche) Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.2.4 Genentech (Roche) Injectable Blood Thinners Products Offered

7.2.5 Genentech (Roche) Recent Development

7.3 Boehringer Ingelheim

7.3.1 Boehringer Ingelheim Corporation Information

7.3.2 Boehringer Ingelheim Description and Business Overview

7.3.3 Boehringer Ingelheim Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.3.4 Boehringer Ingelheim Injectable Blood Thinners Products Offered

7.3.5 Boehringer Ingelheim Recent Development

7.4 Aspen

7.4.1 Aspen Corporation Information

7.4.2 Aspen Description and Business Overview

7.4.3 Aspen Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.4.4 Aspen Injectable Blood Thinners Products Offered

7.4.5 Aspen Recent Development

7.5 Pfizer

7.5.1 Pfizer Corporation Information

7.5.2 Pfizer Description and Business Overview

7.5.3 Pfizer Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.5.4 Pfizer Injectable Blood Thinners Products Offered

7.5.5 Pfizer Recent Development

7.6 Hepalink

7.6.1 Hepalink Corporation Information

7.6.2 Hepalink Description and Business Overview

7.6.3 Hepalink Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.6.4 Hepalink Injectable Blood Thinners Products Offered

7.6.5 Hepalink Recent Development

7.7 King-friend

7.7.1 King-friend Corporation Information

7.7.2 King-friend Description and Business Overview

7.7.3 King-friend Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.7.4 King-friend Injectable Blood Thinners Products Offered

7.7.5 King-friend Recent Development

7.8 CSBIO

7.8.1 CSBIO Corporation Information

7.8.2 CSBIO Description and Business Overview

7.8.3 CSBIO Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.8.4 CSBIO Injectable Blood Thinners Products Offered

7.8.5 CSBIO Recent Development

7.9 Amphastar Pharmaceuticals

7.9.1 Amphastar Pharmaceuticals Corporation Information

7.9.2 Amphastar Pharmaceuticals Description and Business Overview

7.9.3 Amphastar Pharmaceuticals Injectable Blood Thinners Sales, Revenue and Gross Margin (2017-2022)

7.9.4 Amphastar Pharmaceuticals Injectable Blood Thinners Products Offered

7.9.5 Amphastar Pharmaceuticals Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Injectable Blood Thinners Industry Chain Analysis
• 8.2 Injectable Blood Thinners Key Raw Materials
• 8.2.1 Key Raw Materials

8.2.2 Injectable Blood Thinners Distributors

8.3 Injectable Blood Thinners Production Mode & Process

8.4 Injectable Blood Thinners Sales and Marketing

8.4.1 Injectable Blood Thinners Sales Channels

8.4.2 Injectable Blood Thinners Distributors

8.5 Injectable Blood Thinners Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
• 10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

Blood thinners are medications taken orally or intravenously (through a vein) to prevent a blood clot. Blood clots can stop the flow of blood to the heart, lungs, or brain. They can cause a heart attack or stroke. Some anticoagulant medicines are given as a shot (injection). Anticoagulants are also called blood thinners. Examples of these medicines include low-molecular-weight heparin and fondaparinux.
Market Analysis and Insights: Global and United States Injectable Blood Thinners Market

This report focuses on global and United States Injectable Blood Thinners market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Injectable Blood Thinners market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, LMWH accounting for % of the Injectable Blood Thinners global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Injectable Blood Thinners market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Injectable Blood Thinners Scope and Market Size

Injectable Blood Thinners market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Injectable Blood Thinners market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Injectable Blood Thinners market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Injectable Blood Thinners market is segmented into

LMWH

Unfractionated Heparin

Fibrinolytics

Other

Segment by Application, the Injectable Blood Thinners market is segmented into

Hospital

Clinic

Others

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Injectable Blood Thinners Market Share Analysis

Injectable Blood Thinners market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Injectable Blood Thinners business, the date to enter into the Injectable Blood Thinners market, Injectable Blood Thinners product introduction, recent developments, etc.

The major vendors covered:

Sanofi

Genentech (Roche)

Boehringer Ingelheim

Aspen

Pfizer

Hepalink

King-friend

CSBIO

Amphastar Pharmaceuticals